A machine learning diagnostic model for Pneumocystis jirovecii pneumonia in patients with severe pneumonia

被引:5
|
作者
Li, Xiaoqian [1 ]
Xiong, Xingyu [2 ]
Liang, Zongan [2 ]
Tang, Yongjiang [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Pneumocystis jirovecii pneumonia; Severe pneumonia; Machine learning; Diagnostic model; INFECTIOUS-DISEASES SOCIETY; CARINII-PNEUMONIA; PREVENTION; ADULTS;
D O I
10.1007/s11739-023-03353-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe diagnosis of Pneumocystis jirovecii pneumonia (PCP) in patients presenting with severe pneumonia is challenging and delays in treatment were associated with worse prognosis. This study aimed to develop a rapid, easily available, noninvasive machine learning diagnostic model for PCP among patients with severe pneumonia.MethodsA retrospective study was performed in West China Hospital among consecutive patients with severe pneumonia who had undergone bronchoalveolar lavage for etiological evaluation between October 2010 and April 2021. Factors associated with PCP were identified and four diagnostic models were established using machine learning algorithms including Logistic Regression, eXtreme Gradient Boosting, Random Forest (RF) and LightGBM. The performance of these models were evaluated by the area under the receiver operating characteristic curve (AUC).ResultsUltimately, 704 patients were enrolled and randomly divided into a training set (n = 564) and a testing set (n = 140). Four factors were ultimately selected to establish the model including neutrophil, globulin, & beta;-D-glucan and ground glass opacity. The RF model exhibited the greatest diagnostic performance with an AUC of 0.907. The calibration curve and decision curve analysis also demonstrated its accuracy and applicability.ConclusionsWe constructed a PCP diagnostic model in patients with severe pneumonia using four easily available and noninvasive clinical indicators. With satisfying diagnostic performance and good clinical practicability, this model may help clinicians to make early diagnosis of PCP, reduce the delays of treatment and improve the prognosis among these patients.
引用
收藏
页码:1741 / 1749
页数:9
相关论文
共 50 条
  • [31] Echinocandins for Pneumocystis jirovecii pneumonia in non-HIV patients: A case report
    Huang, Hui-Bin
    Peng, Jing-Min
    Du, Bin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (04) : 3227 - 3232
  • [32] Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization A Multicenter, Retrospective Study
    Jiang, Yongpo
    Huang, Xiaohan
    Zhou, Huili
    Wang, Mingqiang
    Wang, Shengfeng
    Ren, Xindie
    He, Guojun
    Xu, Jun
    Wang, Qianqian
    Dai, Muhua
    Xiong, Yonghui
    Zhong, Lin
    He, Xuwei
    Deng, Xuntao
    Pan, Yujie
    Xu, Yinghe
    Cai, Hongliu
    Jin, Shengwei
    Wang, Hongyu
    Huang, Lingtong
    CHEST, 2025, 167 (01) : 54 - 66
  • [33] An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia
    Cartagena, Alexis Jaramillo
    Asowata, Osaretin Emmanuel
    Ng, Dianna
    Babady, N. Esther
    JOURNAL OF CLINICAL MICROBIOLOGY, 2025, 63 (03)
  • [34] Pneumocystis jirovecii Pneumonia in an Infant: The Tip of the Iceberg
    Boillat, Laurence
    Angelini, Federica
    Crucis-Armengaud, Anne
    Asner, Sandra A.
    Rochat, Isabelle
    CLINICAL PEDIATRICS, 2019, 58 (05) : 578 - 581
  • [35] Purine antimetabolites associated Pneumocystis jirovecii pneumonia
    Lukose, Lipin
    Shantaram, Pawar Mansi
    Raj, Alan
    Nair, Gouri
    Shaju, Aina M.
    K. Subeesh, Viswam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (11) : 1244 - 1251
  • [36] Pneumocystis jirovecii Pneumonia: A Revisit to the old Malady
    Meenakshi, Kante
    Gowtham, Racherla Rishi
    Usha, Kalawat
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (11) : DE01 - DE08
  • [37] Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases
    Ghembaza, Amine
    Vautier, Mathieu
    Cacoub, Patrice
    Pourcher, Valerie
    Saadoun, David
    CHEST, 2020, 158 (06) : 2323 - 2332
  • [38] Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review
    Sierra, Caroline M.
    Daiya, Krishna C.
    PHARMACOTHERAPY, 2022, 42 (11): : 858 - 867
  • [39] A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure
    Azoulay, Elie
    Roux, Antoine
    Vincent, Francois
    Kouatchet, Achille
    Argaud, Laurent
    Rabbat, Antoine
    Mayaux, Julien
    Perez, Pierre
    Pene, Frederic
    Nyunga, Martine
    Bruneel, Fabrice
    Klouche, Kada
    Mokart, Djamel
    Darmon, Michael
    Chevret, Sylvie
    Lemiale, Virginie
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (12) : 1519 - 1526
  • [40] The presence of Pneumocystis jirovecii DNA in plasma is associated with a higher mortality rate in patients with AIDS-associated Pneumocystis pneumonia
    Wang, Mengyan
    Dai, Xiahong
    Huang, Ying
    Sun, Jia
    Dong, Xiaotian
    Guo, Yongzheng
    Hu, Caiqin
    Zhou, Qihui
    Zhu, Biao
    MEDICAL MYCOLOGY, 2019, 57 (05) : 582 - 587